Balyasny Asset Management LLC Stryker Corp Put Options Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$315.94 - $371.96 $94,782 - $111,588	300 Added 0.37%	81,300 $29.4 Million
Q2 2024 Aug 14, 2024	BUY	$324.3 - $354.67 $26.3 Million - $28.7 Million	81,000 New	81,000 $27.6 Million
Q4 2023 Feb 14, 2024	SELL	$253.85 - $299.46 $11 Million - $13 Million	-43,300 Reduced 63.4%	25,000 $7.49 Million
Q2 2023 Aug 14, 2023	BUY	$271.49 - $305.09 $6.79 Million - $7.63 Million	25,000 Added 57.74%	68,300 $20.8 Million
Q4 2022 Feb 14, 2023	BUY	$205.51 - $253.93 $8.9 Million - $11 Million	43,300 New	43,300 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$236.63 - $276.44 $3.31 Million - $3.87 Million	14,000 New	14,000 $3.74 Million
Q3 2021 Nov 15, 2021	SELL	$248.9 - $280.09 $796,480 - $896,287	-3,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$242.95 - $267.0 $777,440 - $854,400	3,200 New	3,200 $831,000

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $136B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.